Stephen C. Glover insider trades

Open-market stock purchases and sales by Stephen C. Glover, Director at Oncolytics Biotech Inc, from SEC Form 4 filings since Dec 12, 2022.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -24%.

Recent trades

DateStockTradeValue
Jun 1, 2026ONCY Oncolytics Biotech IncBought (not open market)—
Jan 12, 2026PDSB PDS Biotechnology CorpBought (not open market)—

Companies traded

  • ONCY Oncolytics Biotech Inc: other filings, last Jun 1, 2026
  • PDSB PDS Biotechnology Corp: 1 buy, last Jan 12, 2026
  • ZVSA ZyVersa Therapeutics, Inc: other filings, last Jul 11, 2025
  • AMAM Ambrx Biopharma, Inc: other filings, last Mar 7, 2024

Get free alerts when Stephen C. Glover files a new trade →